YOL083C-A Antibody

What is YOL083C-A and why is it studied in research?

YOL083C-A is an uncharacterized protein found in Saccharomyces cerevisiae (strain 204508/S288c), commonly known as baker's yeast. The protein has a molecular weight of approximately 5,633 Da and is encoded by the YOL083C-A gene . This protein is primarily studied in basic yeast molecular biology research to understand gene expression patterns, protein-protein interactions, and cellular functions in eukaryotic systems. As S. cerevisiae serves as a model organism, insights gained from YOL083C-A research may provide fundamental understanding of conserved cellular processes across eukaryotes.

What are the key specifications of commercially available YOL083C-A antibodies?

Most commercially available YOL083C-A antibodies are rabbit polyclonal antibodies generated against recombinant Saccharomyces cerevisiae YOL083C-A protein. These antibodies typically have the following specifications:

These antibodies are designed for research use only and are not intended for diagnostic procedures .

What are the validated applications for YOL083C-A antibodies in yeast research?

YOL083C-A antibodies have been primarily validated for enzyme-linked immunosorbent assay (ELISA) and Western blot applications in yeast research . These methods allow researchers to:

• Detect and quantify YOL083C-A protein expression levels in different yeast strains or under various experimental conditions using ELISA

• Determine the molecular weight and confirm the presence of YOL083C-A protein in yeast lysates via Western blot

• Investigate post-translational modifications of YOL083C-A protein

• Study protein-protein interactions using co-immunoprecipitation followed by Western blot

When designing experiments with YOL083C-A antibodies, researchers should include appropriate positive controls (wild-type yeast extracts) and negative controls (YOL083C-A knockout strains if available) to validate antibody specificity.

How should researchers optimize Western blot protocols for YOL083C-A detection?

For optimal detection of YOL083C-A protein via Western blot, researchers should consider the following methodological approach:

• Sample preparation:

  • Prepare yeast lysates using glass bead disruption or enzymatic lysis methods

  • Include protease inhibitors to prevent protein degradation

  • Denature samples at 95°C for 5 minutes in reducing sample buffer

• Gel electrophoresis:

  • Use 15-20% SDS-PAGE gels due to the small size of YOL083C-A (5.6 kDa)

  • Consider using Tricine-SDS-PAGE for better resolution of small proteins

• Transfer:

  • Use PVDF membrane with 0.2 μm pore size (rather than 0.45 μm) for small proteins

  • Transfer at lower voltage (30V) overnight at 4°C to prevent small protein loss

• Blocking and antibody incubation:

  • Block with 5% non-fat dry milk or BSA in TBST

  • Incubate with primary YOL083C-A antibody at recommended dilution (typically 1:500 to 1:2000)

  • Use secondary anti-rabbit HRP-conjugated antibody at 1:5000 dilution

• Detection:

  • Use enhanced chemiluminescence (ECL) detection system

  • Consider longer exposure times due to potentially low expression levels

This protocol should be optimized for each specific laboratory condition and antibody lot .

What validation methods should researchers employ to ensure YOL083C-A antibody specificity?

Given the challenges with antibody specificity highlighted in recent literature, researchers should implement multiple validation strategies for YOL083C-A antibodies:

• Genetic validation:

  • Test the antibody in YOL083C-A knockout strains (negative control)

  • Compare with wild-type strains expressing YOL083C-A (positive control)

• Orthogonal validation:

  • Correlate protein detection results with mRNA expression data

  • Use tagged YOL083C-A constructs and detect with both anti-tag and anti-YOL083C-A antibodies

• Independent antibody validation:

  • Compare results from antibodies from different suppliers or different clones

  • Use antibodies targeting different epitopes of YOL083C-A

• Validation across applications:

  • Confirm consistent results across multiple applications (Western blot, ELISA, etc.)

• Recombinant expression validation:

  • Test antibody against purified recombinant YOL083C-A protein

These validation steps are particularly important as many commercial antibodies lack comprehensive validation data, as highlighted in the survey of commercial antibodies targeting Y chromosome-encoded genes .

What are common cross-reactivity issues with YOL083C-A antibodies and how can they be addressed?

When working with antibodies targeting yeast proteins like YOL083C-A, researchers should be aware of potential cross-reactivity issues:

• Cross-reactivity with homologous proteins:

  • YOL083C-A may have homologous proteins in yeast or other organisms

  • Conduct BLAST searches to identify potential cross-reactive proteins

• Verification methods:

  • Pre-adsorption tests with recombinant YOL083C-A protein

  • Immunoprecipitation followed by mass spectrometry to confirm target specificity

  • Competition assays with blocking peptides

• Controls for specificity:

  • Include YOL083C-A knockout strains as negative controls

  • Include recombinant YOL083C-A protein as positive control

  • Test antibody reactivity in non-yeast samples to identify non-specific binding

The survey of commercial antibodies revealed that many antibodies lack specificity validation against potential cross-reactive targets, highlighting the importance of researcher-conducted validation.

How can YOL083C-A antibodies be employed in studying protein-protein interactions?

For investigating protein-protein interactions involving YOL083C-A, researchers can employ several advanced methodological approaches:

• Co-immunoprecipitation (Co-IP):

  • Use YOL083C-A antibody for immunoprecipitation

  • Analyze co-precipitated proteins by mass spectrometry

  • Protocol optimization: Use gentler lysis conditions (non-ionic detergents) to preserve protein-protein interactions

• Proximity ligation assay (PLA):

  • Combine YOL083C-A antibody with antibodies against suspected interaction partners

  • Visualize interactions as fluorescent spots indicating proteins in close proximity

  • Controls: Include known interacting and non-interacting protein pairs

• Chromatin immunoprecipitation (ChIP) for DNA-binding studies:

  • If YOL083C-A has potential DNA-binding properties, use ChIP to identify DNA binding sites

  • Follow with sequencing (ChIP-seq) to map genome-wide interactions

• Pull-down assays with immobilized YOL083C-A antibody:

  • Couple YOL083C-A antibody to a solid support

  • Incubate with yeast lysate and elute binding partners

  • Identify partners by Western blot or mass spectrometry

These techniques provide complementary approaches to build a comprehensive understanding of YOL083C-A's interaction network within yeast cells.

What approaches can be used to study YOL083C-A localization in yeast cells?

Understanding the subcellular localization of YOL083C-A provides insights into its function. Researchers can employ the following methodologies:

• Immunofluorescence microscopy:

  • Fix yeast cells with formaldehyde or methanol

  • Permeabilize cell wall with zymolyase or lyticase

  • Incubate with YOL083C-A primary antibody and fluorescently-labeled secondary antibody

  • Co-stain with organelle markers (nucleus, mitochondria, ER, etc.)

• Subcellular fractionation:

  • Fractionate yeast cells into distinct organellar compartments

  • Analyze fractions by Western blot using YOL083C-A antibody

  • Compare distribution with known organelle marker proteins

• Immunoelectron microscopy:

  • For high-resolution localization studies

  • Use gold-conjugated secondary antibodies to visualize YOL083C-A

  • Controls: Include YOL083C-A knockout strains or peptide competition controls

• Live-cell imaging with fluorescent protein fusions:

  • Create YOL083C-A-GFP fusion constructs

  • Validate functionality of fusion protein

  • Validate localization pattern with immunofluorescence using YOL083C-A antibody

These complementary approaches provide a robust framework for determining YOL083C-A localization and potential functions within specific cellular compartments.

What are common technical challenges when working with YOL083C-A antibodies and how can they be resolved?

Researchers working with YOL083C-A antibodies may encounter several technical challenges:

• Low signal intensity in Western blots:

  • Increase antibody concentration

  • Extend incubation time (overnight at 4°C)

  • Increase protein loading (up to 50-100 μg total protein)

  • Use more sensitive detection systems (ECL-Plus or fluorescent secondary antibodies)

  • Optimize transfer conditions for small proteins

• High background or non-specific bands:

  • Increase blocking time or concentration

  • Reduce primary antibody concentration

  • Include 0.1-0.5% Tween-20 in wash buffers

  • Try alternative blocking agents (BSA instead of milk)

  • Pre-adsorb antibody with non-specific proteins

• Inconsistent results between experiments:

  • Standardize lysate preparation protocols

  • Aliquot antibodies to avoid freeze-thaw cycles

  • Include internal loading controls

  • Consider lot-to-lot variations in antibodies

• Difficulty detecting low-abundance YOL083C-A:

  • Implement enrichment steps (immunoprecipitation before Western blot)

  • Use more sensitive detection methods

  • Consider inducing YOL083C-A expression if regulation is known

When troubleshooting, researchers should always include appropriate controls and document all experimental conditions to facilitate systematic problem-solving .

How should researchers interpret conflicting results obtained with different YOL083C-A antibody clones?

When faced with conflicting results from different YOL083C-A antibody clones or sources, researchers should implement a systematic approach to data interpretation:

• Epitope mapping and analysis:

  • Determine the epitopes recognized by each antibody

  • Consider if post-translational modifications might affect epitope accessibility

  • Evaluate if protein conformation affects antibody binding

• Validation hierarchy assessment:

  • Prioritize results from antibodies with more extensive validation data

  • Consider results from antibodies that have been validated using genetic approaches (e.g., tested in knockout strains)

  • Implement orthogonal validation using non-antibody methods

• Systematic comparison study:

  • Design side-by-side experiments with standardized conditions

  • Test multiple antibody concentrations

  • Document all experimental variables

  • Use multiple detection methods when possible

• Integration with complementary techniques:

  • Confirm key findings with non-antibody-based methods (e.g., mass spectrometry)

  • Correlate protein results with mRNA expression data

  • Consider tagged protein approaches

• Literature assessment:

  • Review published studies using the same antibodies

  • Contact manufacturers for unpublished validation data

  • Engage with other researchers in the field via scientific forums

The industry-wide concerns about antibody specificity highlighted in the survey of commercial antibodies underscore the importance of this systematic approach to resolving conflicting results.

How can YOL083C-A antibodies contribute to understanding yeast protein function and evolution?

YOL083C-A antibodies provide valuable tools for exploring fundamental questions in yeast biology:

• Functional characterization:

  • Monitor YOL083C-A expression under different growth conditions or stresses

  • Identify interaction partners to infer functional roles

  • Study post-translational modifications and their regulation

• Evolutionary studies:

  • Compare YOL083C-A expression and function across different yeast species

  • Investigate conservation of interaction networks

  • Study regulation mechanisms across evolutionary distances

• Systems biology approaches:

  • Integrate YOL083C-A expression data with transcriptomics and proteomics datasets

  • Map YOL083C-A into known signaling or metabolic pathways

  • Create predictive models of YOL083C-A function based on experimental data

• Structural biology applications:

  • Use antibodies to purify native YOL083C-A for structural studies

  • Employ antibodies to study conformational changes under different conditions

Through these applications, YOL083C-A antibodies contribute to building a comprehensive understanding of this uncharacterized yeast protein and its role in cellular functions.

What considerations should researchers have when designing immunogenicity studies involving YOL083C-A?

When designing immunogenicity studies involving YOL083C-A or using it as a model system:

• Antigen design considerations:

  • Select appropriate YOL083C-A regions with predicted immunogenicity

  • Consider protein folding and epitope accessibility

  • Evaluate potential cross-reactivity with host proteins

• Immune response characterization:

  • Analyze both B-cell and T-cell responses

  • Evaluate antibody isotype distribution

  • Measure neutralizing vs. non-neutralizing antibody responses

  • Assess memory B-cell formation

• Adjuvant selection:

  • Test multiple adjuvant formulations

  • Compare response kinetics and durability

  • Evaluate T-cell polarization with different adjuvants

• Analytical methodology:

  • Implement multiple orthogonal assays to characterize immune responses

  • Include competition assays to determine epitope dominance

  • Use surface plasmon resonance to measure antibody affinity

• Translation to other protein systems:

  • Consider how findings with YOL083C-A might translate to other proteins

  • Evaluate structural similarities with therapeutic proteins of interest

These considerations align with FDA guidance on immunogenicity research for protein-based therapeutics, which emphasizes the importance of comprehensive immune response characterization .